4
Changes in Ownership
Cadrenal Therapeutics, Inc. Filed Acc 0001213900-25-103146
CEO and Chairman sold 2,444 shares at an average $14.01 ($34,237)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Pham Quang X · CEO and Chairman
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-24 | Sale : show line 1 in the form 10b5-1 | −1,129 | $14.03 | $15,840 | 197,404 | D |
| 2025-10-27 | Sale : show line 2 in the form 10b5-1 | −1,315 | $13.99 | $18,397 | 196,089 | D |
| Open-market sales · 2,444 sh · avg $14.01 · $34,237 | ||||||
Loading xslF345X05/ownership.xml…